about
Emerging concepts in pancreatic cancer medicine: targeting the tumor stromaInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsAnticoagulation policy after venous resection with a pancreatectomy: a systematic reviewCerebral ischemic events in patients with pancreatic cancer: A retrospective cohort study of 17 patients and a literature reviewElucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.Changes in the Laboratory Data for Cancer Patients Treated with Korean-medicine-based Inpatient Care.Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: a Sarah Cannon Research Institute phase II trial.A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer.A case of cerebral venous thrombosis as the presenting sign of occult prostate cancer.Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.Therapeutic options for the management of pancreatic cancer.New strategies in pancreatic cancer: emerging epidemiologic and therapeutic conceptsSerum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinomaRandomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyPancreatic cancer: A model cancer for the study of the therapeutic effects of anticoagulants.Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer.Selected hemostatic parameters in patients with pancreatic tumors.Association between incident cancer and subsequent stroke.Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium.Is health screening beneficial for early detection and prognostic improvement in pancreatic cancer?Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model.Bile salt-dependent lipase interacts with platelet CXCR4 and modulates thrombus formation in mice and humans.Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival.Immuno-PET of tissue factor in pancreatic cancer.Diagnostic Role of Platelet Lymphocyte Ratio(PLR) in Pancreatic Head Masses.Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.Pancreatic cancer: why is it so hard to treat?Excess premature (3-month) mortality in advanced pancreatic cancer could be related to fatal vascular thromboembolic events. A hypothesis based on a systematic review of phase III chemotherapy studies in advanced pancreatic cancer.Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancerThromboembolism in gastrointestinal cancers.The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis.Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patientsDoes clinical method mask significant VTE-related mortality and morbidity in malignant disease?Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.Anaesthetic perioperative management of patients with pancreatic cancer.Pancreatic Cancer-Induced Neutrophil Extracellular Traps: A Potential Contributor to Cancer-Associated Thrombosis.Preoperative evaluation and management of the pancreatic head mass.How early can pancreatic cancer be recognized? A case report and review of the literature.Current and future therapies for advanced pancreatic cancer.
P2860
Q24627664-E13D6177-4F9C-4BE6-A1FA-0390DA6A3BD9Q27009534-C381725C-997B-4782-85C0-04DB365C145CQ27009646-2ED39342-CF29-438F-A51A-6587580279B2Q27314885-DDA1DE4D-27A6-4700-84FB-1735C6C78007Q30468939-14981814-F562-4A48-ABC6-CE704554B7C4Q30911539-6CCABB14-CC01-4F99-A534-3A913BEEC23EQ33389637-34DD140F-7E18-4316-9052-634E35990EB3Q33405544-8768677D-DD94-4266-B206-E1D2205FDF0FQ33421680-A5E8755F-FDA9-4BE5-B01B-01A7A85A92C5Q33590758-3190F673-0EF8-45FF-AA13-EAC617C21D9DQ33765406-12DE66D7-617E-428F-BB70-F13E2A622114Q34093776-A8B81BA1-7319-4AC3-ABEE-C20D4EA860F4Q34101569-499D5FCF-E336-4D35-AF4E-CE23F464A862Q34185657-60FE8667-B071-484B-B66A-B3DC59C66D9CQ34257664-28B695B2-7635-48BC-8F61-AD754CD80C3EQ34390809-91B83A70-A5A9-49B6-B211-8EE5D5F2BCE8Q34498299-AF28090B-DFB1-4275-89B8-939026DD9755Q34978795-ABA44265-8D3F-44F4-B01A-21DAEE2FC306Q35044297-31C96C8E-C9E4-4B51-96A6-2895A7307007Q35057361-2D666536-9F11-44EB-AB43-17B8ACE5BD82Q35119157-CADEE61D-6FE4-4D44-A289-0992847CF976Q35856677-D3A7927F-C179-4808-95B2-F803E3EFF5B5Q36151685-9922745B-A88E-46CA-9DE0-20A02831BBF2Q36160668-0B6C294A-B8CE-4C67-A783-C544C6BD7708Q36374066-E13B4130-B792-4D42-8140-147AD040E726Q36648293-7177617E-D6D7-467F-8344-DA5F49758F06Q36812718-632DE3FA-8DF1-4AC6-9EE8-8AD2CBDD0A7EQ36886497-DF0256B0-BB4D-48EB-9AFE-52E4E4C6B252Q36980432-3F08835C-E14B-4EA0-A510-DF0C501EAE79Q37040591-669906F4-4965-49F8-BCAC-DE30A2021EDFQ37076622-F0E3BD36-DFAF-4023-B6F2-D7E8E408A391Q37129768-134274A3-6A15-4009-BF83-EB64082AFA7AQ37188178-70195330-E573-4A9C-A07E-C4EAD06E2E92Q37271148-0935552F-4414-4E6E-BD76-745EA843390BQ37438142-64D829AC-EF28-4B63-B525-B95731BB6ECBQ37617968-5FE5D058-A34B-47FD-A46E-BAF3B8ED843EQ37729004-D1AE8832-097E-4749-892B-D7E891C3CCCEQ38016795-BDEB2461-90B6-4FDD-BDA0-756997285C85Q38408810-58402016-0F04-4F8D-820D-9D35521C787CQ38673621-4453CFE8-6794-45F2-831F-1EEF0332B603
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pancreatic cancer and thromboembolic disease.
@ast
Pancreatic cancer and thromboembolic disease.
@en
type
label
Pancreatic cancer and thromboembolic disease.
@ast
Pancreatic cancer and thromboembolic disease.
@en
prefLabel
Pancreatic cancer and thromboembolic disease.
@ast
Pancreatic cancer and thromboembolic disease.
@en
P1433
P1476
Pancreatic cancer and thromboembolic disease
@en
P2093
Robert L Fine
P304
P356
10.1016/S1470-2045(04)01606-7
P577
2004-11-01T00:00:00Z